No products found.
Category
20 products
Vials
A selective NNMT inhibitor studied for reducing fat-cell formation and preserving cellular NAD+ levels.
A modified HGH fragment (176-191) studied for fat metabolism without growth-hormone-linked anabolic activity.
A gastric-derived pentadecapeptide extensively studied for tendon, gut and musculoskeletal tissue repair.
Pharmaceutical-grade sterile water with 0.9% benzyl alcohol, used to safely reconstitute lyophilised peptides.
Mod GRF 1-29, a short-acting GHRH analogue studied for natural, pulsatile growth hormone release.
A pineal tetrapeptide studied for telomerase activation, circadian regulation and cellular longevity research.
A copper-binding tripeptide studied for collagen synthesis, wound healing and skin anti-ageing research.
A long-acting IGF-1 analogue with a 20-30 hour half-life, verified at 98% purity and 1.07mg content.
A selective GHRP pentapeptide studied for growth hormone release with minimal cortisol or appetite effects.
An alpha-MSH-derived tripeptide studied for anti-inflammatory action in gut, skin and immune research.
A mitochondrial-derived peptide studied as an exercise mimetic via AMPK activation and metabolic regulation.
A cyclic α-MSH analogue studied for melanogenesis, photoprotection and broad melanocortin receptor research.
Nicotinamide adenine dinucleotide, a coenzyme central to cellular energy production and DNA repair research.
Bremelanotide, a CNS-acting melanocortin agonist studied for arousal pathways in both sexes.
Thymosin Beta-4, a systemic tissue-repair peptide studied for cell migration, flexibility and wound healing.
A GHRH analogue with the strongest clinical evidence for targeted visceral fat reduction among GH peptides.
